Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit

Thread starter International: Top News And Analysis
Start date May 2, 2025

International: Top News And Analysis

Guest

May 2, 2025

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss drug.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit

Prefix: N/A

Forum: World News

Start date: May 2, 2025

Last reply date: May 2, 2025

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, May 2, 2025

Replies: 0

Views: 68

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search